Clinical implications of fibrinogen and fibrin. Systematic review [Implicaciones clínicas de la Fibrinógeno y Fibrina. Revisión sistemática]
DOI:
https://doi.org/10.62574/9tg4gn47Keywords:
fibrinogen, thrombin, fibrinAbstract
Objective: to analyse the clinical implications of fibrinogen and fibrin. Method: Systematic review. Results and conclusion: Fibrinogen and fibrin are fundamental elements in human physiology, with a direct impact on critical processes such as haemostasis, thrombosis, wound healing and the inflammatory response. Their alteration, whether due to intrinsic or exogenous factors, is closely linked to the development of various pathologies, from cardiovascular diseases to complications associated with COVID-19.
Downloads
References
Litvinov RI, Pieters M, de Lange-Loots Z, Weisel JW. Fibrinogen and Fibrin. Subcell Biochem. 2021;96:471-501. doi:10.1007/978-3-030-58971-4_15
Beudert M, Gutmann M, Lühmann T, Meinel L. Fibrin Sealants: Challenges and Solutions. ACS Biomater Sci Eng. 2022;8(6):2220-2231. doi:10.1021/acsbiomaterials.1c01437
Ząbczyk M, Ariëns RAS, Undas A. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovasc Res. 2023;119(1):94-111. doi:10.1093/cvr/cvad017
Wolberg AS. Fibrinogen and fibrin: synthesis, structure, and function in health and disease. J Thromb Haemost. 2023;21(11):3005-3015. doi:10.1016/j.jtha.2023.08.014
Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022;479(4):537-559. doi:10.1042/BCJ20220016
Gaule TG, Ajjan RA. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges. Int J Mol Sci. 2021;22(13):6916. Published 2021 Jun 28. doi:10.3390/ijms22136916
Feller T, Connell SDA, Ariёns RAS. Why fibrin biomechanical properties matter for hemostasis and thrombosis. J Thromb Haemost. 2022;20(1):6-16. doi:10.1111/jth.15531
Risman RA, Sen M, Tutwiler V, Hudson NE. Deconstructing fibrin(ogen) structure. J Thromb Haemost. 2025;23(2):368-380. doi:10.1016/j.jtha.2024.10.024
Kearney KJ, Ariëns RAS, Macrae FL. The Role of Fibrin(ogen) in Wound Healing and Infection Control. Semin Thromb Hemost. 2022;48(2):174-187. doi:10.1055/s-0041-1732467
Bayer IS. Advances in Fibrin-Based Materials in Wound Repair: A Review. Molecules. 2022;27(14):4504. Published 2022 Jul 14. doi:10.3390/molecules27144504
Hulshof AM, Hemker HC, Spronk HMH, Henskens YMC, Ten Cate H. Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis. Int J Mol Sci. 2021;22(5):2590. Published 2021 Mar 4. doi:10.3390/ijms22052590
Kangro K, Wolberg AS, Flick MJ. Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19. Curr Drug Targets. 2022;23(17):1593-1602. doi:10.2174/1389450123666220826162900
Sidelmann JJ, Gram JB, Rasmussen JJ, Kistorp C. Anabolic-Androgenic Steroid Abuse Impairs Fibrin Clot Lysis. Semin Thromb Hemost. 2021;47(1):11-17. doi:10.1055/s-0040-1714398
Udovenko A, Makogonenko Y, Korolova D, Druzhyna N, Chernyshenko V, Komisarenko S. Formation and elimination of soluble fibrin and D-dimer in the bloodstream. Croat Med J. 2023;64(6):421-429. doi:10.3325/cmj.2023.64.421
Fox T, Hunt BJ, Ariens RA, et al. Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition. Cochrane Database Syst Rev. 2023;7(7):CD015775. Published 2023 Jul 26. doi:10.1002/14651858.CD015775
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Mirka Dayanara Morales-López, Sandra Elizabeth Zambrano-Castillo, Silvia del Pilar Nuñez-Arroba
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
